Discover 1 curated intelligence briefings related to this specific topic.
The transition from borrowing natural viral vectors to designing synthetic, de novo shells is fundamentally altering drug delivery. Recent breakthroughs in AI-designed nucleases and polyepitope mRNA are rendering natural biological constraints obsolete.
